Navigation Links
Hill-Rom Appoints Mark Guinan as Chief Financial Officer
Date:11/1/2010

BATESVILLE, Ind., Nov. 1, 2010 /PRNewswire-FirstCall/ -- Hill-Rom (NYSE: HRC) today announced the appointment of Mark Guinan as Senior Vice President and Chief Financial Officer. Guinan is currently Chief Procurement Officer for Johnson & Johnson, and will officially join Hill-Rom on December 13, 2010.  

During his career with Johnson & Johnson, Guinan held a number of senior financial positions, including Vice President- Finance, Global Pharmaceutical Group, Vice President- Finance, Global R&D and Business Operations, and several positions in their Ethicon Endo-Surgery business.  Prior to Johnson & Johnson, Guinan held positions of increasing responsibility with Proctor & Gamble. Guinan has an undergraduate degree from the University of Notre Dame and an MBA from the Olin Graduate School of Management at Washington University.  

"I am delighted to have someone with Mark's impressive credentials and established capabilities joining our team," said John Greisch, Hill-Rom's President and CEO. "We expect that, under his leadership, Hill-Rom will continue to deliver great operating results and increasing shareholder value in the future."

Guinan succeeds Greg Miller, who has been Hill-Rom's CFO since 2005.  "All of us at Hill-Rom thank Greg for his years of service and wish him well in his future endeavors," said Greisch.

ABOUT HILL-ROM HOLDINGS, INC.

Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions.  Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom…enhancing outcomes for patients and their caregivers.

www.hill-rom.com


'/>"/>
SOURCE Hill-Rom
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hill-Rom Announces Appointment of James R. Giertz to Board of Directors
2. Hill-Rom Announces Corporate Governance Enhancements
3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast
4. Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter
5. Hill-Rom and Encompass Group Form Joint Venture
6. Hill-Rom to Host Investors Conference in New York City
7. Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies
8. Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings
9. Hill-Rom Introduces Smart Bed Technology into CareAssist(R) ES Bed
10. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
11. Hill-Rom Extends Smart Bed Features for High-Tech Hospital Rooms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ... ... rise from USD 20 Billion in 2015 to around USD 26 ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., a ... drug prescribing process, today announced it closed $25 million in ... venture capital firm based in Seattle ... Venture Partners . The Series B round included participation from ... in 2014, and GV (formerly Google Ventures). As ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ... California, committed to raising awareness for Duchenne muscular dystrophy, and funding for ... CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... HR decision-makers are preparing for how his administration could impact the employee benefits ... into what changes are most likely to make it through Congress. His discussion ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... The doctors ... Richmond, BC, who live with dental fear and require sedation to receive dental care. ... at ease during various procedures, from hygienic cleanings to oral surgery, at their dental ...
(Date:4/25/2017)... ... 25, 2017 , ... Patients who would like to straighten ... fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, an ... this revolutionary treatment with or without a referral. , Wilckodontics is also ...
(Date:4/25/2017)... ... 25, 2017 , ... As Spring reignites vigilance against Zika ... to Zika virus during pregnancy, as well as other prenatal exposures like cocaine, ... , The Teratology Society is an international and multidisciplinary group of ...
Breaking Medicine News(10 mins):